February 3, 2010

Sensors for Medicine and Science, Inc., (http://www.s4ms.com) a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced the appointment of Dr. Paul Strumph as the company's Chief Medical Officer. Dr. Strumph was most recently Vice President and Chief Medical Officer of the Juvenile Diabetes Research Foundation.

Diabetes testing products maker Home Diagnostics Inc (HDIX.O) said it agreed to be acquired by Japanese medical devices company Nipro Corp (8086.T) for about $215 million, or $11.50 per share. The offer represents a 90 percent premium to Home Diagnostics' Tuesday close.http://www.reuters.com/article/idUSSGE6120GT20100203